United States · Biotechnology startup
United States · Kalion
Kalion is a biotech company that manufactures high-purity chemicals for the pharmaceutical markets.
Funding reportedLast round: Grant
What company datasets say Kalion raised
Funding, as reported
Reported in all$6.1Min dollars
Rounds9
Last roundGrant
Last round dateJun 2020
Investors listed5
SEC Form D$6.7M sold, 7 filings, last Nov 2023
Founders and team
From Kalion's own website and the SEC filings it signed: 7 on the team.
- Darcy PratherPresident
- Kristala Jones PratherChief Scientist
- Tyler SmithVP of Product Development
- Andy ShaferBoard Member
- Bob MiniuttiBoard Member
- Joan ZiefBoard Member
- Melissa J. KentBoard Member
On the board, as filediAndrew ShaferRobert Miniutti
On a portfolio page
Investors who name them
Each firm lists Kalion on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Kalion in front of investors. Or tell us what we have wrong.